Intra-herb pharmacokinetics interaction between quercetin and isorhamentin

Abstract

Aim: Quercetin and isorhamnetin are common constituents of some herb extracts, such as extracts of gingko leaves and total flavones of Hippophae rhamnoides L. The intra-herb pharmacokinetics interactions between isorhamnetin and quercetin were investigated in the present study. Methods: Human MDR1 cDNA transfected MDCKII cells were used to validate whether isorhamnein interacted with P-gp. Caco-2 transport assays and a randomized, 3-way crossover pharmacokinetics study in rats were used to investigate the pharmacokinetics interactions. HPLC was used to determine cell transport samples. The total plasma concentrations of quercetinand isorhamnetin were determined by liquid chromatography tandem mass spectrometry (LC-MS/MS) by treatment with β-glucuronidase and sulfatase. Results: The permeability ratio (absorptive permeability/secretive permeability) of isorhamnetin across human MDR1 cDNA transfected MDCKII cells, Caco-2 cells and wild-type MDCKII cells are 0.25±0.02, 0.74±0.05, and 1.41±0.06, respectively. This result proved the role of P-gp in the cell efflux of isorhamnetin. While co-transporting with each other across Caco-2 cells monolayer, the permeability ratio of isorhamnetin and quercetin increased by 4.3 and 2.2 times. After coadministration with each other to rats,the C max , AUC 0-72 h , and AUC 0-∞ of both isorhamnetin and quercetin significantly increased compared with single administration. Conclusion:The above results proved intra-herb pharmacokinetics interaction between quercetin and isorhamentin. P-gp might play an important role, whereas other drug efflux pumps, such as multi-drug resistance associate protein 2 and breast cancer resistance protein, might be involved. Accordingly, besides the drug-herb interactions, intra-herb interaction might be brought into view with the wide use of herbal-based remedies.

Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin‐induced diabetic rats

“…However, in our study, although the major form of Cyp3A , i.e. Cyp3A2 , was not significantly changed, Cyp3A1 and Cyp3A9 were significantly increased in the DMIS rats (Figure ). This was consistent with previous results.…”

Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells

“…1) which was a characteristic of carrier-mediated transport. P-gp was reported to alter the pharmacokinetics of numerous structurally and pharmacologically diverse drugs (Dahan and Amidon 2009;Lan et al 2008). And previous studies had reported that P-gp may be involved in the efflux of lignans compounds (Wang 2009;Hye et al 2007).…”

Antidepressant‐like effects of quercetin in diabetic rats are independent of hypothalamic–pituitary–adrenal axis

“…Quercetin is mainly carried by albumin (48) and hence, the albumin concentration is a key determinant for the availability of quercetin. Also, quercetin can interact with other bioactive molecules to change its own affinity to albumin (49)(50)(51). Together with the fact that hyperglycemia proportionally declines the affinity of quercetin to albumin (52), which means there remains more quercetin to excrete in severe hyperglycemia than the mild one, it can be assumed that abovementioned inter-trial differences make it difficult to predict if quercetin will decrease the blood glucose in diabetics.…”